Chemours (NYSE:CC) Sets New 1-Year High - Should You Buy?
Chemours (NYSE:CC) recently hit a new 52-week high of $23.20, trading on strong volume and well above its moving averages. While analyst sentiment is mixed with an average "Hold" rating and $20.40 price target, UBS recently raised its target to $29 and reiterated a "Buy." The company's fundamentals currently show mixed results, including beating EPS expectations but having negative net margin and P/E, alongside a 1.5% dividend yield.
https://www.marketbeat.com/instant-alerts/chemours-nysecc-sets-new-1-year-high-should-you-buy-2026-04-14/